Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

TSO3 Inc T.TOS

Sector: Healthcare | Sub-Sector: Medical Instruments & Supplies

TSO3 Inc. is engaged in the research, development, commercialization, and licensing of sterilization processes and accessories for heat-sensitive medical devices.
Price: $0.49 | Change: $0.00 | % Change: 0.00%
Volume: 136,000 | Day High/Low: 0.495/0.49 | 52 Week High/Low: 1.10/0.40

View modes: 
0 stars

RE:RE:RE:RE:RE:RE:RE:RE:RE:Market simply impatient

So, if Canaccord's target is $1.75 with no probles uncovered concerning the predicate decive, what is TOS worth if issues are uncovered with the predicate device? $2.50? I also like that TOS's own...read more
5 stars

RE:RE:RE:RE:RE:RE:RE:RE:Market simply impatient

"This makes me wonder if the FDA might have some serious quality questions for other manufacturers regarding the testing and quality of the predicate devices already approved, (including previous...read more
0 stars

RE:RE:RE:RE:RE:RE:RE:RE:Market simply impatient

Thanks alot for the update.  I really appreciate it.  rate and reply
0 stars

RE:RE:RE:RE:RE:RE:RE:Market simply impatient

Not sure why you didn't get through. Rumble was excellent in getting back to me, returning my missed call twice before connecting with me. As noted, he was extremely upbeat and satisfied with the...read more
0 stars

RE:RE:RE:RE:RE:RE:Market simply impatient

You talked to rumble today Easter Monday?  I phoned and nobody was there. When does he expect to announce the resubmission?  rate and reply
0 stars

RE:RE:RE:RE:RE:RE:Market simply impatient

Tkx echo, very informative.. If there's no news before agm, I'll go try to get anything but it seems it might not be necessary..  rate and reply
3.5 stars

RE:RE:RE:RE:RE:Market simply impatient

I had a long, frank, and very informative talk with Rumble today. In my opinion, he feels the preparation of the submission is going very well, with all testing complete and the extensive...read more
0 stars

RE:RE:RE:RE:Market simply impatient

desi it is worth a lot more to J&J to get worldwide rights than it is to have half of their employees selling one machine and the half in the other part of the world running the product down so they...read more
0 stars

RE:RE:RE:RE:RE:Market simply impatient

Didn't Rumble used to work for Steris....maybe he still does  rate and reply
0 stars

RE:RE:RE:RE:Market simply impatient

Rumble doesn't want a channel partner if the price isn't what he think TOS is worth. The LOI with Getinge didn't materialize  because of that and that lead to the sell after approval current strategy....read more
0 stars

RE:RE:RE:Market simply impatient

I don"t understand what"s wrong with having the product distributed in Canada and Europe , while waiting for FDA. Someone asked this question in conference, but they said they didn"t want do it that...read more
0 stars

RE:RE:Market simply impatient

"Then why has rumble gone AWOL.? Can't get a hold of anyone for a comment." If it was bad news it doesn't take long to write a news release and tell everyone. Again, I bet they are just putting the...read more
0 stars

RE:Market simply impatient

Yup, at the 18:10 minute mark he said exactly that. The problem is the market assumed he was smart enough to give a conservative forecast so he would have time to get it filed and do a nr, to avoid 1...read more
0 stars

RE:Market simply impatient

Then why has rumble gone AWOL.? Can't get a hold of anyone for a comment.  rate and reply
0 stars

Market simply impatient

Expected data collection by the end of the quarter +/- a few days/weeks but please recognize this is science. Didn't see anything needed beyond the end of the quarter. An extra two weeks of testing...read more
0 stars

RE:RE:RE:I guess investor starting to price in

Even the person who bought at the all time low in Nov 2008 ($0.145) would be wondering if this stock has been a decent investment. If they believed management and held on for "just a little while...read more
0 stars

RE:RE:RE:I guess investor starting to price in

At this rate it will be under 40 soon.  Lets see what Rumble does... other than nothing. He shouldn't give timelines and not respond.  rate and reply
0 stars

RE:RE:I guess investor starting to price in

I ain't going nowhere but I'm not buying more until it get under .40.. The only negative thing that can occurs IMO is additional delays.. They have the cash, they'll figure it out if there is...read more
5 stars

RE:RE:I guess investor starting to price in

There is nothing wrong with management's performance. They don't work at the FDA so couldn't possibly anticipate every dumb question the FDA has asked over the years otherwise they would be doing...read more
4 stars

RE:I guess investor starting to price in

It looks like the market wants an update. I haven't seen any insider selling, and have seen some buying over the last few months. On the conference call it sounded like they were essentially complete....read more